BVX — Bivictrix Therapeutics Share News
0.000.00%
Brief: Bivictrix Therapeutics Says US Patent Granted
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - Holding(s) in Company
Brief: Bivictrix Therapeutics Announces Positive Final Data In Preclinical Efficacy Study
BiVictriX Therapcts. - Positive final data in preclinical efficacy study
BiVictriX Therapcts. - Positive interim data
BiVictriX Therapcts. - Publication of Annual Report and Notice of AGM
Brief: Bivictrix Therapeutics FY Loss After Tax Of £2.5 Mln
BiVictriX Therapcts. - BiVictriX Full Year Results
Brief: BiVictriX Therapeutics Appoints Alex Hughes As Chief Financial Officer
BiVictriX Therapcts. - BiVictriX reports positive BVX001 preclinical data
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - Holding(s) in Company
Brief: Bivictrix Therapeutics Names Michael Kauffman As Chairman
BiVictriX Therapcts. - BiVictriX: Board Change
BiVictriX Therapcts. - BiVictriX identifies lead for BVX001 programme